Data for Sphingolipid Concentrations in Serum for Muscle Wasting in Cancer Cachexia (part-IX) (Study ST001014)
(Analysis AN001656)Values for each metabolite have been scaled by dividing by the mean across all factors Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study| Metabolite | F1 | F2 | F3 | F4 | F5 | F6 |
|---|---|---|---|---|---|---|
| C14-cer | 1.0060 | 0.6826 | 0.8084 | 1.5090 | 1.1856 | 0.8084 |
| C16-cer | 0.8383 | 0.7464 | 0.9902 | 1.8134 | 0.9365 | 0.6752 |
| C18:1-cer | 0.7979 | 0.5745 | 1.0532 | 2.0745 | 0.9574 | 0.5426 |
| C18-cer | 0.6829 | 0.5147 | 1.0436 | 2.4472 | 0.7764 | 0.5352 |
| C20-cer | 0.9694 | 0.6614 | 1.1007 | 1.5932 | 0.9887 | 0.6865 |
| C22-cer | 1.2088 | 0.9395 | 1.1053 | 0.8676 | 1.0743 | 0.8045 |
| C24:1-cer | 0.8777 | 0.7985 | 1.1543 | 1.4454 | 0.9129 | 0.8111 |
| C24-cer | 1.2993 | 1.2000 | 1.0604 | 0.6496 | 0.9938 | 0.7969 |
| C8-cer | NA | NA | NA | NA | NA | NA |
| S1P | 1.6283 | 0.8353 | 0.7631 | 0.8865 | 0.9256 | 0.9612 |
| SPA | 1.6230 | 0.6885 | 0.6393 | 1.1803 | 0.7131 | 1.1557 |
| Sph | 1.7830 | 0.5377 | 0.5472 | 1.1415 | 0.6132 | 1.3774 |
Factors:
| F1 | Grouping:Control | Gender:Female |
| F2 | Grouping:Control | Gender:Male |
| F3 | Grouping:Weight Losing | Gender:Female |
| F4 | Grouping:Weight Losing | Gender:Male |
| F5 | Grouping:Weight Stable | Gender:Female |
| F6 | Grouping:Weight Stable | Gender:Male |
